AXLA
Closed
Axcella Health Inc
0.4009
-4.1791 (-91.25%)
Last Update: 30 Dec 2023 00:00:00
Yesterday: 4.58
Day's Range: 0. - 0.
Send
sign up or login to leave a comment!
When Written:
0.48
Axcella Health Inc is a biotechnology company that is focused on developing novel therapies that target the body's metabolic pathways to treat a range of diseases. The company's proprietary platform is based on the idea that certain amino acids, called "amino acid derivatives," can be used to modulate metabolic pathways and improve health outcomes.
Axcella Health is developing a pipeline of product candidates that target various diseases, including liver and muscle diseases, immune disorders, and neurological disorders. The company's lead product candidate, AXA1665, is being developed for the treatment of non-alcoholic steatohepatitis (NASH), a liver disease that affects millions of people worldwide.
Axcella Health was founded in 2008 and is headquartered in Cambridge, Massachusetts. The company went public in 2019 and is listed on the NASDAQ under the ticker symbol "AXLA."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Axcella Health is developing a pipeline of product candidates that target various diseases, including liver and muscle diseases, immune disorders, and neurological disorders. The company's lead product candidate, AXA1665, is being developed for the treatment of non-alcoholic steatohepatitis (NASH), a liver disease that affects millions of people worldwide.
Axcella Health was founded in 2008 and is headquartered in Cambridge, Massachusetts. The company went public in 2019 and is listed on the NASDAQ under the ticker symbol "AXLA."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








